Curaleaf Holdings Inc T.CURA

Alternate Symbol(s): CURLF

Healthcare Cannabis

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. It cultivates, processes, markets and/or dispenses a range of permitted cannabis products across its operating markets, including flower and pre-rolls, dry-herb vaporizer cartridges, concentrates for vaporizing such as pre-filled vaporizer cartridges and disposable vaporizer pens, concentrates for dabbing, such as mints, topical balms and lotions, tinctures, lozenges, capsules and edibles. Through Curaleaf International Holdings Limited, it has a supply and distribution network throughout the European market.

TSX:CURA - Post by User

Curaleaf Holdings Inc

<< Previous

Bullboard Posts

Next >>

Post by Form001on Apr 30, 2021 2:13pm

81 Views

Post# 33102473

Tobacco maker confirms interest in cannabis business

The cannabis industry received a new form of validation this past week after the multibillion dollar tobacco maker behind Marlboro cigarettes, Philip Morris International (NYSE: PM ), signaled it is intrigued by the potential of entering the cannabis space.

Despite the admission of interest, the tobacco company stopped short of announcing any plans or potential strategy when it comes to a market entry.

“We are doing all this work and will determine one day what avenues to pursue,” Philip Morris CEO Andre Calantzopoulos told Bloomberg News . “But our priority is what we’re doing with our smoke-free products, and that’s where I would stay on cannabis.”

The cannabis space has seen support come in various forms from big-name tobacco and alcohol makers as vice industries set their eyes on a market that was worth US$21 billion globally in 2020 .

Fellow tobacco company Altria Group (NYSE: MO ) holds an investment in Canadian cannabis producer Cronos Group (NASDAQ: CRON ,TSX:CRON), while British American Tobacco (BAT) (NYSE: BTI ,LSE:BATS) recently secured a product partnership with Organigram Holdings (NASDAQ: OGI ,TSX:OGI).